Accessibility Menu
EuroEyes International Eye Clinic logo

EuroEyes International Eye Clinic(SEHK) 1846

Market CapHK$757.22MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2019)-77%
5 Year-80%
1 Year-17%
1 Month-2%
HK$2.44
+0.00%
+0.00Today
EuroEyes International Eye Clinic last closing stock price
MetricPriceDate
Last closeHKD 2.442026-08-31
EuroEyes International Eye Clinic stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-2.4%HKD 2.502026-08-24
1 month-2.4%HKD 2.502026-07-31
3 month-5.06%HKD 2.572026-06-02
Year to date-19.74%HKD 3.042025-12-31
1 year-17.29%HKD 2.952025-08-29
3 year-49.17%HKD 4.802023-09-01
5 year-80.26%HKD 12.362021-09-01
Since inception-76.59%HKD 10.122019-10-15

EuroEyes International Eye Clinic Financials at a Glance

Market Cap

HK$757.22MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

HK$1.51B

Net Income (TTM)

HK$136.74M

EPS (TTM)

HK$0.17

P/E Ratio

13.92

Dividend

HK$0.04

Beta (Volatility)

-0.06 (Low)

Price

HK$2.44

Volume

15,000

Open

HK$2.37

Previous Close

HK$2.44

Daily Range

HK$2.37 - HK$2.44

52-Week Range

HK$2.30 - HK$3.35

Estimated Earnings Date

Aug 31, 2026

1846 News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About EuroEyes International Eye Clinic

EuroEyes International Eye Clinic Limited specializes in vision correction services across Germany, China, Denmark, and the UK. The company offers a range of advanced laser eye surgeries and related services, positioning itself as a leader in the medical care facilities industry.

Products and Services
  • Laser eye surgery options including SMILE Pro and Femto-Lasik
  • Lens exchange surgeries featuring monofocal and trifocal lenses
  • Consultation centers and training services for eye treatment
Growth Outlook
  • Revenue increased to HKD 418.9 million in Q4 2025
  • Net income rose to HKD 16.0 million in the latest quarter
  • Strong demand for vision correction services supports future expansion
Financial Highlights
  • Trailing twelve-month revenue of HKD 1.5 billion
  • Net profit margin of 6.84% reflects operational efficiency
  • Current ratio of 2.79 indicates strong liquidity position
EuroEyes International Eye Clinic Limited has established a robust presence in the healthcare sector, focusing on innovative vision correction solutions. The company has demonstrated consistent revenue growth, with a notable increase in net income in the most recent quarter. The strong demand for its services, coupled with a solid financial foundation, positions EuroEyes favorably for future expansion. The current ratio indicates a healthy liquidity position, allowing for potential investments in new technologies and facilities. Overall, EuroEyes presents a compelling opportunity for investors interested in the healthcare industry, particularly in the growing field of vision correction.
AI Generated • Aug 31, 2026

Industry

Healthcare Providers and Services

Sector

Health Care

Employees

404

CEO

Jørn Slot Jørgensen, MD

Website

www.euroeyes.hk

Headquarters

Hamburg, CQ 20355, DE

1846 Financials

Key Financial Metrics (TTM)

Gross Margin

40.74%

Operating Margin

14.40%

Net Income Margin

6.84%

Return on Equity

4.33%

Return on Capital

6.91%

Return on Assets

2.79%

Earnings Yield

7.18%

Dividend Yield

1.86%

Payout Ratio

37.42%

Stock Overview

Market Cap

HK$757.22MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

319.50M

Volume

15.00K

Avg. Volume

41.55K

Financials (TTM)

Gross Profit

HK$610.93M

Operating Income

HK$230.41M

EBITDA

HK$305.53M

Operating Cash Flow

HK$391.50M

Capital Expenditure

-HK$125.98M

Free Cash Flow

HK$265.52M

Cash & ST Invst.

HK$696.70M

Total Debt

HK$410.19M

EuroEyes International Eye Clinic Performance Analysis

EuroEyes International Eye Clinic annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31HKD 610,291,000-3.6%
20232023-12-31HKD 714,289,00017.0%
20242024-12-31HKD 715,682,0000.2%
20252025-12-31HKD 796,041,00011.2%
EuroEyes International Eye Clinic sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-06-300.1%
Q42024-12-31-5.7%
Q22025-06-308.6%
Q42025-12-3111.1%
EuroEyes International Eye Clinic annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31HKD 0.27-33.6%
20232023-12-31HKD 0.4046.7%
20242024-12-31HKD 0.25-36.9%
20252025-12-31HKD 0.17-31.6%
EuroEyes International Eye Clinic sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-06-30-31.6%
Q42024-12-31-7.7%
Q22025-06-30N/A
Q42025-12-31-58.2%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

HK$418.92M

+13.9%

Gross Profit

HK$167.52M

-0.3%

Gross Margin

39.99%

N/A

Market Cap

HK$757.22MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

HK$2.15M

N/A

Employees

352

N/A

Net Income

HK$16.05M

-74.8%

EBITDA

HK$69.85M

-32.0%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Total Cash

HK$696.70M

-3.3%

Total Debt

HK$410.19M

+6.7%

Accounts Receivable

HK$32.85M

+289.3%

Inventory

HK$15.15M

-6.3%

Long Term Debt

HK$326.02M

+4.0%

Short Term Debt

HK$84.17M

+19.0%

Return on Assets

2.79%

N/A

Return on Invested Capital

6.85%

N/A

Free Cash Flow

HK$77.86M

+39.3%

Operating Cash Flow

HK$92.15M

-7.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,684.24-0.00%
^DJIDJI
$53,254.61-0.01%
^IXICNASDAQ
$26,319.55-0.00%
BTCBitcoin
$78,890.00-0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
PCGPG&E
$13.27-0.20%
NVDANvidia
$220.78+0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.97+0.11%
CNHCNH Industrial
$11.83+0.01%

Questions About 1846

What is the current price of EuroEyes International Eye Clinic?

EuroEyes International Eye Clinic is trading at HK$2.44 per share.

What is the 52-week range for EuroEyes International Eye Clinic?

Over the past 52 weeks, EuroEyes International Eye Clinic has traded between HK$2.30 and HK$3.35.

How much debt does EuroEyes International Eye Clinic have?

As of the most recent reporting period, EuroEyes International Eye Clinic reported total debt of HK$410.19M.

How much cash does EuroEyes International Eye Clinic have on hand?

EuroEyes International Eye Clinic reported HK$696.70M in cash and cash equivalents in its most recent financial results.

What is EuroEyes International Eye Clinic’s dividend yield?

EuroEyes International Eye Clinic currently has a dividend yield of 1.86%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services